The publication in 2013 of 3 negative randomized trials comparing endovascular treatment (EVT) with IV rtPA vs. IV rtPA alone was really disappointing for the neurointerventional community, even if these trials had several drawbacks restricting their clinical importance.1 One major drawback was the heterogeneity of endovascular techniques used, and recent studies have established the value of second-generation devices (stent retrievers) in the management of acute ischemic stroke (AIS).2 The efficacy of stent-retriever mechanical thrombectomy (MT) was confirmed in a study by Friedrich et al showing that recanalization (TICI 3/2b) was obtained in 78.1% of 73 patients with acute stroke in the anterior circulation.3 Successful recanalization was associated with a final infarct volume significantly smaller compared with insufficient recanalization (TICI 2a and less). The rescue of a large amount of endangered brain tissue was significantly associated with clinical improvement of the patients at 3 months.
The negative 2013 trials have prompted active research in order to improve the results of EVT in AIS, prompting more intense focus on better selection of patients and optimization of endovascular techniques. In an interesting subanalysis of the STAR study, Almekhlafi et al evaluated the impact of Stroke Prognostication using Age and NIHSS Stroke Scale (SPAN) (age + NIHSS score) on clinical outcomes after MT.4 SPAN-100-positive patients (SPAN ≥ 100) had a significantly lower proportion of favorable clinical outcomes at 3 months (26.7% vs. 60.8% in SPAN-100-negative; P = .01), despite a similar rate of successful reperfusion. In multivariate analysis, SPAN-100 was a significant predictor of favorable outcome (OR = 0.3) as well as baseline ASPECTS (OR = 1.3) and time from stroke onset to successful revascularization (OR = 0.7). As stated by the authors, the SPAN-100 index may be promising as a simple tool to enhance the patient-selection process for MT.
Improving MT technique requires first an understanding of the mechanisms that can potentially alter the clinical outcome of patients.
One potential mechanism is embolism in previously unaffected vessels. In a nice documented series, Kurre et al showed that anterior cerebral artery emboli occurred in 11.4% of 105 patients with M1 recanalization, leading to 5.7% new infarcts.5 This series showed that endovascular recanalization of occluded major anterior cerebral artery branches reduced the risk of ischemia and was not accompanied with adverse events. The authors suggested that recanalization has to be attempted when collateral circulation is poor and accessibility is good. Several strategies are proposed by the authors to reduce the risk of thrombus loss, including improving visualization of the thrombus with advanced imaging techniques, using low-profile microcatheters, positioning of a large-lumen intermediate catheter in the proximity of the thrombus, and using balloon-guided catheters. Further studies are needed to evaluate the value of these different strategies.
Another important issue with MT in AIS treatment is to know whether it is preferable to perform the procedure under general anesthesia or conscious sedation. Soize et al reported a series of 36 patients with AIS treated with MT under conscious sedation.6 They showed that MT was feasible in a high percentage of cases (86.1%) and associated with a short procedure delay and a high percentage of good clinical outcomes at 3 months (61.1%). Other series are showing similar results. AIS procedures have to be carried out in the presence of an experienced anesthesiologist, or where these specialists are immediately available. Anesthesiologists can manage untoward events rapidly, including securing the airway.2 Conscious sedation can be used if the procedure is feasible according to the clinical status. In the case of agitation, upper airway obstruction, or important pain, general anesthesia can be performed at any time during the management of the patient (before or during the EVT).